Ypsomed Holding AG: certificati turbo CALL PUT Prodotti di Borsa e derivati | YPSN

Prodotti derivati

0e3c9f5e3d09708d.jwydsJpfO4ouBeb1O-fGL5P8bGK0nH14IdY3Az1Pc1Q.5Dvb3qI6avx_dYuiaqyDWL6lByjw6AUUEJFuako2OgXbZKj53hNu5mNBqw

Mnemo	Tipo	Tipo di prodotto	Maturità	Elasticità	Leva	Parità	Quotazioni	Emittente
RMACUV CALL	CALL	Certificati Azionari e Obbl.ri	22/04/2025		-	0.678	103 101.4	Vontobel
WYPAPV CALL	CALL	Warrant	20/06/2025	5.73x	-	50	0.405 0.365	Vontobel
WYPARV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	6.26x	-	50	0.35 0.31	Vontobel
WYPASV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	14.16x	-	50	0.078 0.038	Vontobel
WYPANV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	5.79x	-	50	0.445 0.405	Vontobel
WYPAQV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	12.06x	-	50	0.138 0.098	Vontobel
WYPAGV CALL	CALL	Warrant Plain-Vanilla	20/06/2025	4.9x	-	50	0.64 0.6	Vontobel
WYPALV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	5.51x	-	50	0.56 0.52	Vontobel
WYPAOV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	10.23x	-	50	0.228 0.188	Vontobel
RYPABV CALL	CALL	Certificati Azionari e Obbl.ri	12/03/2026		-	0.358	95.9 95.6	Vontobel
WYPAJV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	4.93x	-	50	0.72 0.68	Vontobel
WYPACV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	4.41x	-	50	0.94 0.9	Vontobel
WYPADV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	7.6x	-	50	0.56 0.52	Vontobel
WYPAHV CALL	CALL	Warrant Plain-Vanilla	20/06/2025	3.85x	-	100	0.54 0.52	Vontobel
WYPAEV CALL	CALL	Warrant Plain-Vanilla	21/06/2024	6.04x	-	50	0.84 0.8	Vontobel
WYPAIV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	3.86x	-	100	0.6 0.58	Vontobel
WYPAFV CALL	CALL	Warrant Plain-Vanilla	20/12/2024	3.41x	-	100	0.74 0.72	Vontobel
WYPAKV CALL	CALL	Warrant Plain-Vanilla	20/06/2025	3.05x	-	100	0.81 0.79	Vontobel
RYPAAV CALL	CALL	Certificati Azionari e Obbl.ri	21/10/2024		-	0.249	101.2 100.9	Vontobel

Tempo differito Swiss Exchange Altri mercati azionari 17:31:59 30/04/2024			Variaz. 5gg	Var. 1 gen.
329 ^CHF	-1,79%		-9,99%	+8,58%

12/04	L'azienda di apparecchiature dentali Straumann nomina un nuovo presidente	MT
11/04	L'utile core del primo trimestre di Gerresheimer soddisfa il consenso	RE